The Hidden Cost of “Pre‑Approval” in Health Care

Many people think health insurance is simple: you pay a premium, and the company covers what your doctor recommends. In reality, most patients must first ask for permission before a treatment can be paid for. This step, called prior authorization, often turns simple care into a long battle. Take the story of a 31‑year‑old woman from Virginia. She suffers from a painful nerve condition that makes her limbs feel like they are on fire. Her doctor prescribed a costly blood plasma treatment called IVIG, which can ease her symptoms. The insurance company refused to pay for it twice, forcing the woman’s family to dip into a retirement account and spend nearly $90, 000. Finally, an independent review forced the insurer to reverse its decision, sparing the family from further out‑of‑pocket costs. The relief was real, but it also revealed a bigger problem: thousands of patients face the same denial process every year. In 2024, government officials claimed that insurers would simplify prior authorization by limiting the number of treatments needing approval and speeding up decisions. Yet, when health‑care leaders were asked for details, many could not list specific procedures that would no longer need approval. Some companies did make modest changes—bundling requests for certain surgeries or dropping approvals for specific diagnostic tests—but experts say these are not enough to solve the systemic issue.Patient advocates argue that insurers prioritize profit over patients. “Their duty is to shareholders, not patients, ” one CEO said. The result is that people with chronic illnesses—who need continuous medication or procedures—often find their care delayed or denied. A recent survey found that 39% of such patients say prior authorization is the biggest obstacle to receiving treatment. The problem also shows up in everyday stories. A young woman who received a heart transplant was suddenly denied coverage for her life‑saving medication, risking the loss of her drug supply. Another patient fighting a rare lung disease had to wait months for an insurer to reverse a denial, only to face another request next year. Families often rely on friends or crowdfunding to cover the gap while waiting for approval. Even when an insurer finally grants coverage, it can feel like a temporary fix. The woman from Virginia will lose her current plan soon and may need to switch providers, potentially triggering a new round of approval requests. She worries that the cycle will continue, draining her energy and resources. The real question is whether insurers will follow through on their promises. While some changes are being made, many experts say the reforms lack transparency and depth. Until patients can see clear, consistent rules for when prior authorization is needed—and feel confident that their care won’t be delayed—this hidden cost will keep growing.